| disease activity |
333 |
| leptin |
333 |
| neopterin |
333 |
| rheumatoid arthritis |
333, 371, 306, 299 |
| exercise |
314 |
| lipoprotein receptor related protein 5 |
314 |
| messenger ribonucleic acid expression |
314 |
| osteoporosis |
314 |
| complex regional pain syndrome |
359 |
| erythrocyte |
359 |
| neuroinflammation |
359 |
| platelet |
359 |
| fatigue |
329 |
| scale |
329 |
| systemic sclerosis |
329, 364 |
| turkish version |
329, 321 |
| ankylosing spondylitis |
353 |
| atrial conduction time |
353 |
| carotid intima-media thickness |
353 |
| epicardial fat thickness |
353 |
| anakinra |
377 |
| canakinumab |
377 |
| colchicine |
377 |
| glucocorticoids |
377 |
| schnitzler’s syndrome |
377 |
| burden |
371 |
| caregiver |
371 |
| self-care deficit |
371 |
| health-related quality of life |
321 |
| psoriatic arthritis |
321 |
| validity and reliability |
321 |
| vitacora-19 |
321 |
| high resolution computed tomography |
364 |
| medsger scale |
364 |
| thoracic ultrasonography |
364 |
| polymorphism |
306 |
| tumor necrosis factor alpha |
306 |
| claudin-5 |
299 |
| matrix metalloproteinase-9 |
299 |
| neuroserpin |
299 |
| diabetes |
340 |
| glucosamine |
340 |
| glucose metabolism |
340 |
| insulin resistance |
340 |
| osteoarthritis |
340 |
| arthralgia |
381 |
| ischiopubic synchondrosis |
381 |
| overuse |
381 |
| recurrent pain |
381 |
